<DOC>
	<DOCNO>NCT02678975</DOCNO>
	<brief_summary>Disulfiram ( Antabuse® ) well-tolerated , cheap , generic drug use since 1950s treat alcoholism . There increase amount independent preclinical data support disulfiram anticancer agent . The potency disulfiram anticancer agent seem strengthen copper . The investigator aim investigate disulfiram copper-supplement add-on treatment glioblastoma patient recurrence receive alkylating chemotherapy .</brief_summary>
	<brief_title>Disulfiram Recurrent Glioblastoma</brief_title>
	<detailed_description>Disulfiram ( Antabuse® ) well-tolerated , cheap , generic drug use since 1950s treat alcoholism . There increase amount independent preclinical data support disulfiram anticancer agent . The potency disulfiram anticancer agent seem strengthen copper . There anecdotal clinical evidence disulfiram anticancer agent . So far clinical study publish glioma patient , two small , uncontrolled study plan accord clinicaltrials.gov . search 1st November 2015 . The investigator aim investigate disulfiram copper-supplement add-on treatment glioblastoma patient recurrence receive alkylating chemotherapy . The study perform multicenter RCT include patient Norway Sweden . This serve proof-of concept study . The primary end-point survival 6 month</detailed_description>
	<mesh_term>Glioblastoma</mesh_term>
	<mesh_term>Temozolomide</mesh_term>
	<mesh_term>Alkylating Agents</mesh_term>
	<mesh_term>Copper</mesh_term>
	<mesh_term>Disulfiram</mesh_term>
	<criteria>1 . A previous diagnosis glioblastoma ( histologically verify ) present first progression/recurrence document MRI . 2 . Indication treatment chemotherapeutic alkylating agent ( i.e . temozolomide OR lomustine include PCV treatment ) . 3 . Age 18 year old . 4 . Karnofsky performance status 60 100 . 5 . Not receive another experimental treatment glioblastoma moment inclusion active treatment within assign group ( i.e . control disulfiram group ) . 6 . Able take oral medication . 7 . No known allergy disulfiram copper . 8 . Absolute neutrophil count ≥ 1,500/mcL platelet ≥ 100,000/mcL 9 . Serum/plasma copper serum ceruloplasmin within institutional limit . . However increased level see together ongoing acute phase reaction determine elevated Creactive protein ( ceruloplasmin elevate part process ) possible retest normalization Creactive protein . 10 . Willing refrain ingestion alcoholic beverage study criterion randomize . However , randomize alcohol abstinence affect group treat disulfiram , group include entire period one month last dosage disulfiram . 1 . Earlier treatment progression ( e.g . `` rescue therapy '' ) 2 . History idiopathic seizure disorder , psychosis schizophrenia . 3 . History uncontrolled hypertension ( i.e . systolic BP &gt; 180 mmHg ) diagnosis congestive heart failure 4 . Received radiotherapy within 3 month diagnosis progression . 5 . Addiction alcohol drug . 6 . Pregnant and/or breastfeeding . 7 . Women childbearing potential negative pregnancy test old 14 day enrollment . 8 . History active liver disease , include chronic active hepatitis , viral hepatitis ( hepatitis B , C CMV ) , cholestatic jaundice etiology toxic hepatitis inadequate hepatic function , define baseline ASAT ALAT &gt; 2.5 X upper institutional limit and/or bilirubin &gt; 2.0 X upper institutional limit . 9 . History Wilson 's disease family member Wilson 's disease ( unless exclude carrier genetic test ) . 10 . History hemochromatosis family member hemochromatosis ( unless exclude carrier genetic test ) . 11 . Nickel hypersensitivity ( disulfiram mobilize nickel cause brief increase nickel concentration excretion . The initial increase may lead hepatitis predisposed patient ) . 12 . Need metronidazole , warfarin and/or theophylline medication ( metabolism may influence disulfiram ) . 13 . Patients take medication metabolize cytochrome P450 2E1 , include chlorzoxazone halothane derivative ( phenytoin , phenobarbital , chlordiazepoxide , imipramine , diazepam , isoniazid , metronidazole , warfarin , amitriptyline within 14 day prior first dose disulfiram . Of note , lorazepam oxazepam affect P450 system contraindicate disulfiram ) . 14 . Unfit participation reason judge include physician .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>